CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)
NCT ID: NCT01239914
Last Updated: 2022-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
11719 participants
OBSERVATIONAL
2005-01-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Korean Coronary Overlapping Stenting Registy
NCT02472496
Multicenter Registry of Very Early and Late Clinical Outcomes to Everolimus-eluting Cobalt-Chromium Stent In Patients With ST Elevation Myocardial Infarction
NCT02792920
Study on Prediction of Left Ventricular Remodeling Using ST2
NCT03841214
Prospective Registry to Assess the Cath Lab Percutaneous Coronary Intervention Long-term Outcomes: a Single Center
NCT02498470
Optical Coherence Tomography to Improve Clinical Outcomes During Coronary Angioplasty
NCT02065102
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent for the DNA and serum databank
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul St. Mary's Hospital
OTHER
Yeouido St. Mary's Hospital
OTHER
Bucheon St. Mary's Hospital
OTHER
St.Paul's Hospital, Korea
OTHER
Incheon St.Mary's Hospital
OTHER
Saint Vincent's Hospital, Korea
OTHER
Daejeon St. Mary's hospital
OTHER
The Catholic University of Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kiyuk Chang, MD,PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ki-Bae Seung, M.D.,PhD
Role: STUDY_CHAIR
Seoul St. Mary's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bucheon St.Mary Hospital
Bucheon-si, Gyeonggido, South Korea
St.Vincent's Hospital
Suwon, Gyeonggido, South Korea
Uijeongbu St.Mary's Hospital
Uijeongbu-si, Gyeonggido, South Korea
Daejeon St.Mary's Hospital
Daejeon, , South Korea
Incheon St.Mary's Hospital
Incheon, , South Korea
Seoul St.Mary's Hospital
Seoul, , South Korea
St.Paul's Hospital
Seoul, , South Korea
Yeouido St.Mary Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kim HS, Chang K, Koh YS, Park MW, Choi YS, Park CS, Oh M, Kim EY, Shon JH, Shin JG, Seung KB. CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina. Circ Cardiovasc Genet. 2013 Oct;6(5):514-21. doi: 10.1161/CIRCGENETICS.113.000109. Epub 2013 Sep 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COACT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.